These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 37277196)

  • 21. Global Vaccine Access Demands Combating Both Inequity And Hesitancy.
    Hotez PJ
    Health Aff (Millwood); 2023 Dec; 42(12):1681-1688. PubMed ID: 38048497
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Shaping meeting to explore the value of a coordinated work plan for epidemic and pandemic influenza vaccine preparedness.
    Ruscio B; Bolster A; Bresee J;
    Vaccine; 2020 Apr; 38(16):3179-3183. PubMed ID: 32171576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improving pandemic preparedness through better, faster influenza vaccines.
    Newland M; Durham D; Asher J; Treanor JJ; Seals J; Donis RO; Johnson RA
    Expert Rev Vaccines; 2021 Mar; 20(3):235-242. PubMed ID: 33576708
    [No Abstract]   [Full Text] [Related]  

  • 24. Efficacy and effectiveness of seasonal and pandemic A (H1N1) 2009 influenza vaccines in low and middle income countries: a systematic review and meta-analysis.
    Breteler JK; Tam JS; Jit M; Ket JC; De Boer MR
    Vaccine; 2013 Oct; 31(45):5168-77. PubMed ID: 24012574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lessons learned from 2 years of influenza vaccinations in the UK and USA during the COVID-19 pandemic as respiratory viruses return.
    Tan LJ; Ahmed S; Rothholz MC; Kassianos G; Nguyen-Van-Tam JS
    Hum Vaccin Immunother; 2022 Nov; 18(6):2125754. PubMed ID: 36162068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccines: New challenges, new paradigms, new opportunities: Report of the 22nd DCVMN Annual General Meeting.
    Kumar Suri R; Hayman B; Prasad SD; Makhoana M; Tippoo P
    Vaccine; 2022 Jun; 40(26):3495-3505. PubMed ID: 35577632
    [TBL] [Abstract][Full Text] [Related]  

  • 27. COVID-19 vaccines.
    Ndwandwe D; Wiysonge CS
    Curr Opin Immunol; 2021 Aug; 71():111-116. PubMed ID: 34330017
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Whole Inactivated Virus and Protein-Based COVID-19 Vaccines.
    Hotez PJ; Bottazzi ME
    Annu Rev Med; 2022 Jan; 73():55-64. PubMed ID: 34637324
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021-22 Influenza Season.
    Grohskopf LA; Alyanak E; Ferdinands JM; Broder KR; Blanton LH; Talbot HK; Fry AM
    MMWR Recomm Rep; 2021 Aug; 70(5):1-28. PubMed ID: 34448800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spillover effects of the COVID-19 pandemic on attitudes to influenza and childhood vaccines.
    Soveri A; Karlsson LC; Antfolk J; Mäki O; Karlsson L; Karlsson H; Nolvi S; Karukivi M; Lindfelt M; Lewandowsky S
    BMC Public Health; 2023 Apr; 23(1):764. PubMed ID: 37098527
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Working Hard or Hardly Working? Regulatory Bottlenecks in Developing a COVID-19 Vaccine.
    Pregelj L; Hine DC; Oyola-Lozada MG; Munro TP
    Trends Biotechnol; 2020 Sep; 38(9):943-947. PubMed ID: 32600777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccine complacency and dose distribution inequities limit the benefits of seasonal influenza vaccination, despite a positive trend in use.
    Palache A; Rockman S; Taylor B; Akcay M; Billington JK; Barbosa P;
    Vaccine; 2021 Oct; 39(41):6081-6087. PubMed ID: 34521551
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Which roads lead to access? A global landscape of six COVID-19 vaccine innovation models.
    Alonso Ruiz A; Bezruki A; Shinabargar E; Large K; Vieira M; Slovenski I; Liu Y; Agarwal S; Becker A; Moon S
    Global Health; 2024 Mar; 20(1):25. PubMed ID: 38532484
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inequity in access to vaccines: the failure of the global response to the COVID-19 pandemic.
    Ugalde A; Hellmann F; Homedes N
    Salud Colect; 2022 Oct; 18():e4190. PubMed ID: 36520487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Consideration on implementation of co-administration of Seasonal Influenza and COVID-19 vaccines during pandemic in China].
    Zhang T; Bai XF; Wang W; Liu XX; Zhang XX; Wang DY; Zhang SB; Chen ZP; He HQ; Huang ZY; Xu AQ; Peng ZB; Feng LZ; Yu WZ; Feng Z
    Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Feb; 56(2):103-107. PubMed ID: 34954956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. WHO initiative to increase global and equitable access to influenza vaccine in the event of a pandemic: supporting developing country production capacity through technology transfer.
    Friede M; Palkonyay L; Alfonso C; Pervikov Y; Torelli G; Wood D; Kieny MP
    Vaccine; 2011 Jul; 29 Suppl 1():A2-7. PubMed ID: 21684422
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fogarty International Center collaborative networks in infectious disease modeling: Lessons learnt in research and capacity building.
    Nelson MI; Lloyd-Smith JO; Simonsen L; Rambaut A; Holmes EC; Chowell G; Miller MA; Spiro DJ; Grenfell B; Viboud C
    Epidemics; 2019 Mar; 26():116-127. PubMed ID: 30446431
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Leveraging lessons from the COVID-19 pandemic to strengthen low-income and middle-income country preparedness for future global health threats.
    Alakija A
    Lancet Infect Dis; 2023 Aug; 23(8):e310-e317. PubMed ID: 37290474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Global COVID-19 Vaccine Inequity: Failures in the First Year of Distribution and Potential Solutions for the Future.
    Pilkington V; Keestra SM; Hill A
    Front Public Health; 2022; 10():821117. PubMed ID: 35321196
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.